It has recently been shown to be involved in counteracting the activity of the hCG/vascular endothelial growth factor pathway and therefore may also attenuate ovarian hyperstimulation syndrome (OHSS) symptoms (40). This evidence concerns the gene VEGFA and ovarian hyperstimulation syndrome.